nGyn Secures FDA Approval in USA

May 2022

​

NSV's cervical cancer screening device, nGyn, received FDA approval in the United States. The NSV nGyn system is a Class II FDA Exempt Device under the PTZ designation for use as a digital colposcope. NSV's manufacturing is compliant with the latest ISO and GMP standards required by the FDA.